Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6NCya-Cct4em1/Cya
Common Name:
Cct4-KO
Product ID:
S-KO-01384
Background:
C57BL/6NCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Cct4-KO
Strain ID
KOCMP-12464-Cct4-B6N-VA
Gene Name
Cct4
Product ID
S-KO-01384
Gene Alias
2610204B21Rik; A45; Cctd
Background
C57BL/6NCya
NCBI ID
12464
Modification
Conventional knockout
Chromosome
11
Phenotype
MGI:104689
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6NCya-Cct4em1/Cya mice (Catalog S-KO-01384) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000173867
NCBI RefSeq
NM_009837
Target Region
Exon 2~7
Size of Effective Region
~4.5 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Cct4, a member of the chaperonin containing TCP1 complex, is a key component of the CCT chaperone complex. It is involved in protein folding, and is associated with pathways like mTOR signaling [1]. CCT4 has been found to be important in maintaining proteostasis, a crucial biological process for cell survival and function [5].

In various cancers, CCT4 has shown significant roles. In glioblastoma, YB-1 protein binds to the 5'UTR of CCT4 mRNA to promote its translation, which in turn activates the mTOR signaling pathway, promoting tumor growth [1]. In esophageal squamous cell carcinoma, CCT4 is highly expressed, and its knockdown inhibits glycolysis, enhances cisplatin sensitivity, and affects cell proliferation, migration, apoptosis, and cell cycle [2]. In hepatocellular carcinoma, CCT4 is upregulated, and its knockdown inhibits tumor cell proliferation, induces apoptosis, and interacts with Cdc20 to regulate anaphase-promoting complex activity [3]. In breast cancer, CCT4 is overexpressed and is involved in the LINC01234/hsa-miR-30c-2-3p/CCT4/mTOR axis, promoting malignant behaviors of cancer cells [6]. In contrast, in Wilms tumor, CCT4 is downregulated and may play a reverse regulatory role, potentially through the ErbB signaling pathway [4]. Also, a compound anticarin-β can specifically bind to and inhibit CCT4, showing anti-osteosarcoma effects by impairing proteostasis [5].

In conclusion, CCT4 plays essential roles in protein folding and is intricately involved in multiple cancer-related biological processes. The study of CCT4 using gene-knockout or conditional-knockout models, as inferred from these findings, could potentially provide further insights into its role in cancer development and progression, offering potential therapeutic targets for these diseases.

References:

1. Wang, Jin-Zhu, Zhu, Hong, You, Pu, Wang, Zefeng, Hui, Jingyi. . Upregulated YB-1 protein promotes glioblastoma growth through a YB-1/CCT4/mLST8/mTOR pathway. In The Journal of clinical investigation, 132, . doi:10.1172/JCI146536. https://pubmed.ncbi.nlm.nih.gov/35239512/

2. Fang, Jiarui, Ma, Yingchao, Li, Ya, Ma, Shanshan, Guan, Fangxia. 2022. CCT4 knockdown enhances the sensitivity of cisplatin by inhibiting glycolysis in human esophageal squamous cell carcinomas. In Molecular carcinogenesis, 61, 1043-1055. doi:10.1002/mc.23460. https://pubmed.ncbi.nlm.nih.gov/36102200/

3. Li, Feng, Liu, Chun-Sheng, Wu, Ping, Pan, Qi, Li, Xiao-Ning. 2021. CCT4 suppression inhibits tumor growth in hepatocellular carcinoma by interacting with Cdc20. In Chinese medical journal, 134, 2721-2729. doi:10.1097/CM9.0000000000001851. https://pubmed.ncbi.nlm.nih.gov/34732665/

4. Wang, Haoyuan, Zhang, Lei, Liu, Bin, Su, Jianzhi, Ni, Xiaochen. . Role of CCT4/ErbB signaling in nephroblastoma: Implications for a biomarker of Wilms tumor. In Medicine, 102, e33219. doi:10.1097/MD.0000000000033219. https://pubmed.ncbi.nlm.nih.gov/37058032/

5. Wang, Gan, Zhang, Min, Meng, Ping, Sheng, Xia, Lai, Ren. 2022. Anticarin-β shows a promising anti-osteosarcoma effect by specifically inhibiting CCT4 to impair proteostasis. In Acta pharmaceutica Sinica. B, 12, 2268-2279. doi:10.1016/j.apsb.2021.12.024. https://pubmed.ncbi.nlm.nih.gov/35646538/

6. Tang, Chuangang, Li, Changwen, Chen, Chengling, Wang, Pei, Han, Conghui. . LINC01234 promoted malignant behaviors of breast cancer cells via hsa-miR-30c-2-3p/CCT4/mTOR signaling pathway. In Taiwanese journal of obstetrics & gynecology, 63, 46-56. doi:10.1016/j.tjog.2023.09.019. https://pubmed.ncbi.nlm.nih.gov/38216268/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest